StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioAge Labs's total debt was $0 at Jun 30, 2026. For fiscal 2025 it was $2.65M, down 68.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.65M-68.9%
FY2024Dec 31, 2024$8.50M-40.1%
FY2023Dec 31, 2023$14.20M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$1.16M-83.6%
Q4 FY2025Dec 31, 2025$2.65M-68.9%
Q3 FY2025Sep 30, 2025$4.13M-58.5%
Q2 FY2025Jun 30, 2025$5.60M-60.6%
Q1 FY2025Mar 31, 2025$7.06M–
Q4 FY2024Dec 31, 2024$8.50M–
Q3 FY2024Sep 30, 2024$9.94M–
Q4 FY2023Dec 31, 2023$14.20M–

More BioAge Labs figures

See a number that looks wrong?